Toggle Nav
Close
  • Menu
  • Setting

Anti-NCAM1/CD56 Antibody (Lorvotuzumab)

Catalog No.
F2113
Anti-NCAM1/CD56 Antibody (Lorvotuzumab)
Grouped product items
SizePriceStock Qty
100ug
$90.00
Ship with 3-5 days
1mg
$271.00
Ship with 3-5 days
5mg
$706.00
Ship with 3-5 days
50mg
$2,364.00
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Lorvotuzumab is a humanized monoclonal antibody derived from mouse monoclonal antibodies and modified by genetic engineering. Its composition includes the antibody structure of the IgG1 subtype. The mechanism of action of Lorvotuzumab is to inhibit the growth and spread of tumor cells by targeting the CD56 molecule (neural cell adhesion molecule, NCAM) and blocking its signaling pathway. It is mainly used to treat cancers that express CD56, such as small cell lung cancer and multiple myeloma.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145.5 kDa

Shipping

Dry ice

Cas No.

339306-30-8

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

1 mg/mL

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

hLorvotuzumab, IMGN901

Buffer System

100 mM Pro 20 mM Arg pH 5.0.

Reactivity

Human

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Target

NCAM1/CD56

Note

Please avoid freeze-thaw cycles.